Clinical trial
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT00303719 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00303719 |
|---|---|
| Title | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy |
| Official title | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine, mycophenolate mofetil, stem cell transplantation, total body irradiation, filgrastim |
| Enrollment | 342 |
| Start date | Mar 26, 2002 |
| Primary completion | May 8, 2019 |
| Completion | May 8, 2019 |
| First posted | Mar 17, 2006 |
| Last update posted | May 12, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: